HK1129112A1 - 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders - Google Patents

2 -alkyl- indazole compounds for the treatment of certain cns-related disorders

Info

Publication number
HK1129112A1
HK1129112A1 HK09108893.2A HK09108893A HK1129112A1 HK 1129112 A1 HK1129112 A1 HK 1129112A1 HK 09108893 A HK09108893 A HK 09108893A HK 1129112 A1 HK1129112 A1 HK 1129112A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
treatment
related disorders
indazole compounds
certain cns
Prior art date
Application number
HK09108893.2A
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Nicola Cazzolla
Guido Furlotti
Caterina Maugeri
Rosella Ombrato
Lorenzo Polenzani
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1129112A1 publication Critical patent/HK1129112A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK09108893.2A 2006-11-22 2009-09-25 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders HK1129112A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002230A ITMI20062230A1 (it) 2006-11-22 2006-11-22 Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
PCT/EP2007/010000 WO2008061688A1 (en) 2006-11-22 2007-11-19 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders

Publications (1)

Publication Number Publication Date
HK1129112A1 true HK1129112A1 (en) 2009-11-20

Family

ID=38474157

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108893.2A HK1129112A1 (en) 2006-11-22 2009-09-25 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders

Country Status (23)

Country Link
US (1) US8507528B2 (ja)
EP (1) EP2099780B1 (ja)
JP (1) JP5551443B2 (ja)
KR (1) KR101471987B1 (ja)
CN (1) CN101558057B (ja)
AR (1) AR063881A1 (ja)
AU (1) AU2007323368B2 (ja)
BR (1) BRPI0718976A2 (ja)
CA (1) CA2668205C (ja)
DK (1) DK2099780T3 (ja)
EA (1) EA019217B1 (ja)
ES (1) ES2401199T3 (ja)
GE (1) GEP20125414B (ja)
HK (1) HK1129112A1 (ja)
IL (1) IL198432A (ja)
IT (1) ITMI20062230A1 (ja)
MX (1) MX2009005250A (ja)
PL (1) PL2099780T3 (ja)
PT (1) PT2099780E (ja)
SG (1) SG176504A1 (ja)
SI (1) SI2099780T1 (ja)
UA (1) UA98311C2 (ja)
WO (1) WO2008061688A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2556074T1 (sl) * 2010-04-08 2015-04-30 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A Triciklična indazolna spojina, postopek priprave in farmacevtski sestavek, ki jo vsebuje
ES2564972T3 (es) 2011-03-18 2016-03-30 Bayer Intellectual Property Gmbh Derivados de N-(3-carbamoilfenil)-1H-pirazol-5-carboxamida y su uso para combatir parásitos animales

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436913A (en) * 1980-09-05 1984-03-13 Siegfried Aktiengesellschaft 1H- and 2H- indazole derivatives
GB8623142D0 (en) * 1986-09-26 1986-10-29 Beecham Group Plc Compounds
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
JPH02215779A (ja) * 1989-02-14 1990-08-28 Kuraray Co Ltd カルボン酸アミド誘導体類及びその医薬用途
US5246947A (en) * 1991-09-23 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression
WO1994005642A1 (en) 1992-08-28 1994-03-17 Ciba-Geigy Ag Indazole derivatives
JPH08277287A (ja) 1995-02-09 1996-10-22 Mitsubishi Chem Corp インダゾール類およびその用途
WO1996038420A1 (fr) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Derives de l'indazole a groupe amino monocyclique
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
US6218390B1 (en) * 1998-12-17 2001-04-17 Synaptic Pharmaceutical Corporation Morpholinone and morpholine derivatives and uses thereof
CN100439341C (zh) 2002-12-02 2008-12-03 弗·哈夫曼-拉罗切有限公司 作为促肾上腺皮质激素释放因子拮抗剂的吲唑衍生物
ITMI20030972A1 (it) 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
FR2857966A1 (fr) * 2003-07-24 2005-01-28 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
CA2551171C (en) * 2003-12-23 2012-07-10 Bio-Medisinsk Innovasjon As Modulators of peripheral 5-ht receptors
WO2005066163A2 (en) * 2004-01-05 2005-07-21 Astrazeneca Ab Thiophene derivatives as chk 1 inihibitors
TW200605886A (en) * 2004-08-03 2006-02-16 Wyeth Corp Indazoles useful in treating cardiovascular diseases
TW200621237A (en) * 2004-11-01 2006-07-01 Wyeth Corp [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones
PE20061130A1 (es) * 2004-11-19 2007-01-05 Arena Pharm Inc Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
WO2008054748A2 (en) * 2006-10-31 2008-05-08 Arena Pharmaceuticals, Inc. Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto

Also Published As

Publication number Publication date
DK2099780T3 (da) 2013-04-15
EP2099780B1 (en) 2013-01-09
US20100056573A1 (en) 2010-03-04
SG176504A1 (en) 2011-12-29
MX2009005250A (es) 2009-05-28
CN101558057B (zh) 2013-05-01
EP2099780A1 (en) 2009-09-16
ITMI20062230A1 (it) 2008-05-23
AU2007323368A1 (en) 2008-05-29
KR20090089880A (ko) 2009-08-24
KR101471987B1 (ko) 2014-12-12
SI2099780T1 (sl) 2013-03-29
UA98311C2 (ru) 2012-05-10
PT2099780E (pt) 2013-03-11
ES2401199T3 (es) 2013-04-17
AU2007323368B2 (en) 2013-02-07
IL198432A (en) 2013-03-24
CN101558057A (zh) 2009-10-14
IL198432A0 (en) 2010-02-17
CA2668205C (en) 2014-10-21
AR063881A1 (es) 2009-02-25
EA200970496A1 (ru) 2009-10-30
CA2668205A1 (en) 2008-05-29
BRPI0718976A2 (pt) 2014-02-04
EA019217B1 (ru) 2014-02-28
JP2010510265A (ja) 2010-04-02
JP5551443B2 (ja) 2014-07-16
US8507528B2 (en) 2013-08-13
GEP20125414B (en) 2012-03-12
PL2099780T3 (pl) 2013-05-31
WO2008061688A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
IL192692A0 (en) Compounds for the treatment of inflammatory disorders
EP1976377A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
EP1983972A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
IL192691A0 (en) Hydantoin compounds for the treatment of inflammatory disorders
IL195203A0 (en) Compounds for the treatment of metabolic disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
EP1981526A4 (en) ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
EP2019683A4 (en) DELIVERY OF GROWTH FACTORS TO TREAT CNS DISORDERS
EP2139475A4 (en) USE OF PDE7 INHIBITORS IN THE TREATMENT OF
ZA200805645B (en) Compounds for the treatment of metabolic disorders
ZA200806455B (en) Use of 2-imidazoles for the treatment of CNS disorders
IL192877A0 (en) Use of 2-imidazoles for the treatment of cns disorders
IL192851A0 (en) Compounds for the treatment of metabolic disorders
ZA200908724B (en) Spiro compounds for treatment of inflammatory disorders
ZA201204391B (en) Compounds for the treatment of neurologic disorders
IL195392A0 (en) Compounds for the treatment of metabolic disorders
PL1982178T3 (pl) Sposoby leczenia zaburzeń afektywnych
EP2023894A4 (en) FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
HK1129112A1 (en) 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
IL192982A0 (en) Compounds for the treatment of metabolic disorders
GB0604772D0 (en) Use of substituted amine compounds for the treatment of food related disorders
GB0604783D0 (en) Use of substituted oxime compounds for the treatment of food related disorders
GB0724947D0 (en) Composition for the treatment of psychiatric disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191121